ArticleHepatology (Baltimore, Md.)2015

Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14.

Matias Avila et al.PubMed ↗Publisher ↗

No numbers read from the abstract.